NASDAQ:AMDA - Amedica Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $0.4820 0.00 (0.00 %) (As of 07/20/2018 04:00 PM ET)Previous Close$0.4810Today's Range$0.4630 - $0.500152-Week Range$0.45 - $6.96Volume265,321 shsAverage Volume557,699 shsMarket Capitalization$2.13 millionP/E RatioN/ADividend YieldN/ABeta-1.09 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. The company offers silicon nitride implants to surgeons and hospitals for use in cervical and thoracolumbar spine surgery under the Valeo brand. It also provides a line of non-silicon nitride spinal fixation products to address spinal deformity and degenerative conditions. The company markets and sells its products directly; and through a network of independent sales distributors, as well original equipment manufacturer and private label partnerships. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah. Receive AMDA News and Ratings via Email Sign-up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical SymbolNASDAQ:AMDA CUSIPN/A Webwww.amedica.com Phone801-839-3500 Debt Debt-to-Equity RatioN/A Current Ratio0.45 Quick Ratio0.30 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$11.22 million Price / Sales0.19 Cash FlowN/A Price / CashN/A Book Value$1.80 per share Price / Book0.27 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-9,320,000.00 Net Margins-118.97% Return on Equity-137.30% Return on Assets-64.44% Miscellaneous Employees33 Outstanding Shares4,420,000Market Cap$2.13 Amedica (NASDAQ:AMDA) Frequently Asked Questions What is Amedica's stock symbol? Amedica trades on the NASDAQ under the ticker symbol "AMDA." When did Amedica's stock split? How did Amedica's stock split work? Amedica shares reverse split on Friday, November 10th 2017. The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 9th 2017. An investor that had 100 shares of Amedica stock prior to the reverse split would have 8 shares after the split. How were Amedica's earnings last quarter? Amedica Co. (NASDAQ:AMDA) released its quarterly earnings data on Tuesday, November, 21st. The medical equipment provider reported ($0.93) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.94) by $0.01. The medical equipment provider had revenue of $2.96 million for the quarter. Amedica had a negative return on equity of 137.30% and a negative net margin of 118.97%. View Amedica's Earnings History. When is Amedica's next earnings date? Amedica is scheduled to release their next quarterly earnings announcement on Tuesday, August, 21st 2018. View Earnings Estimates for Amedica. What is the consensus analysts' recommendation for Amedica? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amedica in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." Who are some of Amedica's key competitors? Some companies that are related to Amedica include Regenicin (RGIN), United American Healthcare (UAHC), Avinger (AVGR), Atossa Genetics (ATOS), Viatar CTC Solutions (VRTT), Cytori Therapeutics (CYTX), Encision, Inc. Common Stock (ECIA), Calmare Therapeutics (CTTC), Invivo Therapeutics (NVIV), Delcath Systems (DCTHD), AdvanSource Biomaterials Corpration Common Stock (ASNB), TearLab (TEAR), OxySure Therapeutics (OXYS), Quantrx Biomedical (QTXB) and Scivanta Medical (SCVM). Who are Amedica's key executives? Amedica's management team includes the folowing people: Dr. B. Sonny Bal, Chairman, CEO, Pres & Principal Financial Officer (Age 56)Mr. Bryan J. McEntire, Chief Technology Officer (Age 66)Mr. David O'brien, GM & VP OperationsMr. Dana Lyons, VP of Sales & Marketing Has Amedica been receiving favorable news coverage? News headlines about AMDA stock have trended somewhat positive on Saturday, according to Accern. Accern ranks the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Amedica earned a news impact score of 0.09 on Accern's scale. They also assigned headlines about the medical equipment provider an impact score of 45.32 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. How do I buy shares of Amedica? Shares of AMDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Amedica's stock price today? One share of AMDA stock can currently be purchased for approximately $0.4820. How big of a company is Amedica? Amedica has a market capitalization of $2.26 million and generates $11.22 million in revenue each year. Amedica employs 33 workers across the globe. How can I contact Amedica? Amedica's mailing address is 1885 WEST 2100 SOUTH, SALT LAKE CITY UT, 84119. The medical equipment provider can be reached via phone at 801-839-3500 or via email at [email protected] MarketBeat Community Rating for Amedica (NASDAQ AMDA)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 158 (Vote Outperform)Underperform Votes: 106 (Vote Underperform)Total Votes: 264MarketBeat's community ratings are surveys of what our community members think about Amedica and other stocks. Vote "Outperform" if you believe AMDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMDA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/21/2018 by MarketBeat.com StaffFeatured Article: Are Wall Street analysts' stock ratings worth following?